Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network will generate as many versions as the people you ask. Most likely, we will miss many...

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Norway finds its path in life science

The life science sector in Norway is on the rise.

Gastillverkning i labbet

IATT:s gasgeneratorserie Airogen tar bort behovet av gascylindrar för vätgas, kvävgas och ultraren luft.

Krönika: Collaboration across borders

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Droppbaserad PCR tillåter exakt molekylkvantifiering

Arbete i mindre volymer har visat sig vara nödvändigt för att uppnå de tilltagande kraven på singel-molekylkänslighet som finns inom life science. Detta återspe...

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

Multilabel plate readers with luminescence capability

The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...

Raka spåret in i USA

Euris sluter avtal med det amerikanska bolaget Ocean Nano Tech, som ska distribuera bolagets produkter på den amerikanska marknaden.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

De får Forska och Väx-pengar

59 företag får dela på 66 miljoner kronor i senaste Vinnova-utdelningen. 20 är life science-företag.

Olinks plattform ska användas i stort brittiskt analysprojekt

Genom att analysera proteinplasma från 53 000 britter hoppas de tio deltagande biofarmabolagen utveckla bättre läkemedel.